|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 2877 | Drugs / Medical | 11/10/2003
Kahn Gauthier Swick is investigating possible legal actions against Cordis Corporation on behalf of persons who have been injured by the company's Cypher coronary stent. On October 29, 2003, the federal Food and Drug Administration issued a warning that a significant number of adverse effects had been reported since the Cypher stent was approved on April 24. Both blood clotting and hypersensitivity reactions have been reported.
The FDA announced that it had received more than 290 reports worldwide of thrombosis (clotting) occurring one to 30 days after the procedure to implant the stent. 260 of these reports were from the U.S. In more than 60 of these reports, use of the device was associated with the death of the patient; in the remainder, the device was associated with injury requiring medical or surgical intervention. The FDA has also received more than 50 reports, including some deaths, that may be hypersensitivity reactions. The symptoms include pain, rash, respiratory alterations, hives, itching, fever, and blood pressure changes. The Cypher stent was approved for patients undergoing angioplasty procedures to open clogged coronary arteries. The stent, a cylindrical metal mesh, is designed to keep the arteries from re-clogging after the procedure. It is coated with a thin polymer containing the drug sirolimus that is slowly released into the patient and is intended to reduce the rate of re-blockage that occurs with other stents. As of October 10, 2003, Cordis reports that more than 450,000 Cypher stents have been distributed worldwide, with more than 260,000 of these in the U.S. The FDA does not have enough information to determine whether the incidents of thrombosis and hypersensitivity reaction with the Cypher stent differ from those experienced with bare metal stents. Register your Cordis ComplaintIf you or someone you know has been affected by this case, you may qualify for a money settlement as the result of your financial/economic or other damages that may be awarded either prior to a lawsuit or after the initiation of a lawsuit either currently in progress or filed just for you, possibly a class action lawsuit. Please simply register your complaint by clicking here for Cordis, or click the red "submit" button on this page, and a lawyer will review your Cordis complaint. By submitting your complaint, you are asking lawyers to contact you. You are under no obligation to accept their services and you are free to choose which lawyer you want to work with. Lawyers are usually paid out of the proceeds of the settlement or verdict rendered - the lawyers work on "contingency" by fronting the costs of your lawsuit based on their belief that they will recover a settlement for you. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest A class action has been filed on behalf of search and rescue, demolition and cleanup workers, as well as local residents exposed to lethal toxins at the World Trade Center site after the September 11 terrorist attacks. The suit alleges that the workers, and potentially hundreds of thousands of New Yorkers living in the immediate vicinity, contracted serious illnesses as a result of toxic exposure. The complaint further projects that many others who were exposed but do not yet show symptoms will become ill in coming years as a result of their exposure. Several class actions have been filed against hospice operator Vistacare, Inc. (Nasdaq:VSTA), and certain of its officers and directors by stockholders who purchased the company's common stock between November 6, 2003, and August 5, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. A class action lawsuit has been filed in the Northern District Court of Texas against Eyelane, Inc., a Texas optometrist for violations of the Fair Labor Standards Act (FLSA). Class members seek unpaid compensation, attorney's fees, costs and interest. A small number of men have lost eyesight in one eye some time after taking Viagra, Cialis, or Levitra. This type of vision loss is called non-arteritic anterior ischemic optic neuropathy (NAION). NAION causes a sudden loss of eyesight because blood flow is blocked to the optic nerve. A class-action lawsuit recently filed alleges that Medicare has failed to properly enroll millions of low-income seniors and disabled beneficiaries into its new prescription drug plan. The suit, filed in Oakland on behalf of three women and two senior-advocacy groups, also alleges that some low-income beneficiaries eligible for a subsidy were not properly notified about it or not receiving it. As a result of the problems, many seniors and others who qualify for the program are going without critical medication, said lead attorney Jeanne Finberg of the National Senior Citizens Law Center.
State and federal privacy laws protect your confidential records from sale and use in many situations. A class action has been filed against CVS Corporation, Trio Drugs Corporation, and Manhattan pharmacist Gerald Hinderstein on behalf of pharmacy customers who allege that Trio and its pharmacist violated their fiduciary duties to their customers and committed deceptive business practices when they sold prescription drug records to CVS. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
